Journal of International Oncology ›› 2016, Vol. 43 ›› Issue (8): 664-668.doi: 10.3760/cma.j.issn.1673422X.2016.09.006

Previous Articles     Next Articles

Expressions and clinicopathological significances of BMI1 and PADI4 in esophageal squamous cell carcinoma

Ji Huaijun, Liu Peng, Zhen Tianchang, Su Gongzhang, Sun Ningbo, Jiang Zhongmin   

  1. Graduate School, Weifang Medical College, Weifang 261053, China
  • Online:2016-09-08 Published:2016-08-04
  • Contact: Jiang Zhongmin E-mail:qyjzm@sina.cn
  • Supported by:

    Science and Technology Promotion Foundation of Shandong Province of China (2013GSF11836)

Abstract: 【Abstract】ObjectiveTo evaluate the expression levels of peptidylarginine deiminase 4 (PADI4) and Bcells pecific Moloney leukemia virus insert site1 (BMI1) in esophageal squamous cell carcinoma (ESCC) tissues and pericarcinous tissues. To explore the function and clinical significance in the development of ESCC and their association. MethodsThe expression levels of PADI4 and BMI1 were measured by immunohistochemistry, Western blotting and quantitative real time PCR in ESCC tissues and pericarcinous tissues from 86 patients. The relationships between the expressions of PADI4 and BMI1 and the clinicopathologic characteristics were analyzed. ResultsThe immunohistochemistry showed that the expressions of PADI4 and BMI1 in ESCC tissues (68.6% and 73.3%) were significantly higher than those in pericarcinous tissues (37.2% and 30.2%, χ2=17.011, P=0.000; χ2=31.876, P=0.000). Western blotting indicated that the levels of PADI4 and BMI1 were higher than those in pericarcinous tissues (0.919±0.098 vs. 0.718±0.103, t=2.462, P=0.021; 0.975±0.074 vs. 0.717±0.071, t=2.640, P=0.014). The expressions of BMI1 and PADI4 mRNA in ESCC tissues were higher than those in pericarcinous tissues, but the differences were not statistically significant (0.091±0.005 vs. 0.038±0.002, t=1.701, P=0.101; 0.114±0.075 vs. 0.048±0.003, t=1.499, P=0.146) by the quantitative real time PCR. The expression of PADI4 was correlated with lymph node metastasis (χ2=5.771, P=0.016), depth of invasion (χ2=6.672, P=0.010) and clinical stage (χ2=5.771, P=0.016). The BMI1 gene expression had a correlation with lymph node metastasis (χ2=7.176, P=0.007), the differentiation degree (χ2=13.787, P=0.001) and clinical stage (χ2=7.176, P=0.007). In addition, there was a positive correlation between PADI4 and BMI1 expression in ESCC by immunohistochemistry and quantitative real time PCR (r=0.214, P=0.047; r=0.534, P=0.005). ConclusionThe expression levels of PADI4 and BMI1 are significantly higher in ESCC compared to pericarcinous tissues. PADI4 and BMI1 are positively correlated and may contribute to the diagnosis and prognosis of the ESCC.

Key words: Esophageal neoplasms, Peptidylarginine deiminase 4, Bcells pecific Moloney leukemia virus insert site1